Evolution of the Average Target: Royal Philips

Data source: Philips NV(PHIA)

Evolution of the Target Price: Royal Philips

Data source: Philips NV(PHIA)

Changes in Analyst Recommendations: Royal Philips

Data source: Philips NV(PHIA)
78d6ea315.CDGy6OX6wp6rRA519pUNU9v9dHYlcJmEM6dJCnLrnHk.WV3Knqyct_XSDUocg8xnYLCNNwBSA9K0XMM4bhWTyi1LW9Gp3M6215NxSw~3f96ecf66a3c53433a3bb11d8e92f62a
09-09 Philips NV : JP Morgan reiterates its Neutral rating ZD
08-03 UBS Downgrades Koninklijke Philips to Neutral, Cuts PT MT
08-03 PHILIPS NV : UBS revises his opinion and turns to Neutral ZD
07-31 RBC Tweaks Philips Forecast After Q2 Results; Sector Perform Maintained MT
07-30 PHILIPS NV : Deutsche Bank reaffirms its Neutral rating ZD
07-29 PHILIPS NV : Receives a Buy rating from DZ Bank ZD
07-29 PHILIPS NV : Bernstein sticks Neutral ZD
07-29 PHILIPS NV : JP Morgan reiterates its Neutral rating ZD
07-28 Koninklijke Philips NV: Caution in Q3 overshadows the underlying business strength, presenting a buying opportunity Alphavalue
07-28 PHILIPS NV : RBC reiterates its Neutral rating ZD
07-28 PHILIPS NV : Bernstein remains Neutral ZD
07-28 PHILIPS NV : JP Morgan reaffirms its Neutral rating ZD
07-16 MedTech facing a three-front squeeze Alphavalue
07-07 PHILIPS NV : JP Morgan gives a Neutral rating ZD
07-07 PHILIPS NV : Jefferies is Neutral ZD
07-02 Bernstein: Philips Still On Track for FY26 Goals Despite Expected Q2 Margin Dip MT
06-30 PHILIPS NV : Bernstein remains Neutral ZD
06-30 RBC Tweaks Estimates for Philips on Currency Moves, Share Issuance; Sector Perform Rating Kept MT
06-25 PHILIPS NV : Buy rating from Goldman Sachs ZD
06-23 PHILIPS NV : JP Morgan reiterates its Neutral rating ZD
05-14 Philips Estimates Adjusted as RBC Notes Q2 Margin Headwinds MT
05-14 PHILIPS NV : Jefferies remains Neutral ZD
05-11 DZ Bank Sticks With a Buy on Philips Zonebourse
05-11 PHILIPS NV : DZ Bank reiterates its Buy rating ZD
05-11 Bernstein Keeps Philips at Market-Perform After Q1 Top-line Beat; EPS Forecasts Trimmed MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-0.97%
+8.16%
+21.11%
+42.5%
+14.39%
+20.52%
+11.81%
+5%
-15.43%
Average +11.90%
Weighted average by Cap. +10.43%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
21.60EUR
Average target price
26.90EUR
Spread / Average Target
+24.51%
High Price Target
35.00EUR
Spread / Highest target
+62.04%
Low Price Target
22.00EUR
Spread / Lowest Target
+1.85%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
B
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!